连续灌流微重力模拟3D灌流微重力培养系统DARC-P2.0L 型号: DARC-P2.0L | 价格: 请联系我们详询,谢谢！ 赛吉生物DARC-P2.0L系统是基于自主研发的微重力模拟技术打造的创新型类器官培养平台，专为空间医学研究领域设计。该系统通过高精度算法实现0.001g±0.0005g级超低重力环境模拟，几乎可复现空间站微重力条件，支持科研人员在地面开展三维类器官构建、空间生物学效应研究及药效评估。配套开发的多样化材质微流控芯片矩阵，可灵活适配细胞培养、组织工程、药物筛选等不同实验场景需求。系统突破传统重力模拟技术局限，以持续稳定的微重力环境控制为核心优势，为空间生命科学研究提供从基础机制探索到临床前测试的全流程解决方案，助力航天医学与再生医学领域的技术突破。 热线电话: +86 0 15995516226、+86 0 13862149980 电子邮箱: info@sage-bio.com、carlos_wei@sage-bio.com 留言咨询收藏 攸寻医疗科技科技欢迎您留言 ... ... 为及时与您取得联系并回复您的关注，请务必输入您的姓名、咨询内容及有效的联系电话等，谢谢！ 仅作联络之用，我司承诺保密，敬请放心填写！ ※ 会员提交咨询后，可登录网站进入“会员中心 - 我的咨询”查看管理员的回复内容；非会员提交的咨询，回复内容不会在前台公开显示。 留言加载中... 在线留言咨询 咨询内容： 联系人： 已自动填入（可修改） 联系电话： 已自动填入（可修改） 电子邮箱： 已自动填入（可修改） 验证码： ×

图片展示

DARC-P2.0S&双供液通道	微重力模拟连续灌流主机	DARC-P2.0S全套 (不含培养容器）

产品概述

       赛吉生物 DARC-P2.0L 系统，是为空间医学研究开发的创新型科研设备，核心功能在于地面精准模拟太空微重力环境。其应用范畴不仅覆盖空间生命科学、航天医学领域，对于需依托三维灌流技术的多学科研究场景同样具备高适配性 —— 例如在肿瘤微环境构建、组织工程支架培养、干细胞定向分化研究中，其稳定的灌流体系可保障细胞三维生长所需的营养供给与代谢平衡；同时也适用于药物渗透性测试、体外器官模型培育及病原微生物感染机制研究等场景，为非空间领域的三维实验提供可靠技术支撑。

       该系统依托自主研发的微重力模拟技术，可满足科研人员无需进入太空即可开展空间生物学效应研究的需求；结合连续灌流技术动态更新培养液，有效解决传统静态培养中代谢废物堆积问题，保障细胞正常生长。配套的多材质微流控芯片可适配细胞培养、药物筛选等不同实验需求，覆盖从基础机制探索到临床前测试的全研究流程，为多学科科研工作提供一体化技术解决方案。

The DARC-P2.0L system developed by Saige Bio is an innovative scientific research device designed specifically for space medicine research, with its core function of accurately reproducing the microgravity environment of space on the ground. Its application scope not only covers the fields of space life sciences and aerospace medicine but also exhibits high adaptability to multidisciplinary research scenarios requiring 3D perfusion technology—for instance, in tumor microenvironment construction, tissue engineering scaffold culture, and directed stem cell differentiation research, its stable perfusion system ensures the nutrient supply and metabolic balance required for 3D cell growth. It is also applicable to scenarios such as drug permeability testing, in vitro organ model cultivation, and pathogenic microorganism infection mechanism research, providing reliable technical support for 3D experiments in non-space fields.

Relying on independently developed microgravity simulation technology, the system enables researchers to conduct space biological effect studies without entering space. Combined with continuous perfusion technology to dynamically update the culture medium, it effectively solves the problem of metabolic waste accumulation in traditional static culture and ensures normal cell growth. The supporting multi-material microfluidic chips can adapt to different experimental needs such as cell culture and drug screening, covering the entire research process from basic mechanism exploration to preclinical testing, and providing an integrated technical solution for multidisciplinary scientific research.

优势介绍

       赛吉生物 DARC-P2.0L 系统是空间医学研究领域的突破性科研工具，核心目标是 “在地面复现太空环境”。依托自主研发的微重力模拟技术，它能精准营造接近空间站的微重力条件，科研人员无需依赖航天资源，就能开展三维类器官构建、空间生物学效应研究等关键实验。技术层面突破了传统重力模拟的局限，实现微重力环境的持续稳定控制；同时融合连续灌流技术，动态更新培养液，从根本上解决静态培养中代谢废物堆积的问题，保障细胞正常生长发育。配套的微流控芯片矩阵采用多样化材质，能灵活适配细胞培养、药物筛选等不同场景，进一步拓展了系统的应用边界。功能上覆盖从基础机制探索到临床前测试的全流程，为空间生命科学、航天医学及再生医学提供完整解决方案，相当于搭建起地面与太空研究之间的桥梁。

Saige-Bio's DARC-P2.0L system stands as a groundbreaking research tool in the field of space medicine, with its core goal of "reproducing the space environment on the ground". Leveraging independently developed microgravity simulation technology, it accurately creates microgravity conditions similar to those on the space station—allowing researchers to conduct key experiments (such as 3D organoid construction and space biological effect studies) without relying on aerospace resources. Technically, it breaks through the limitations of traditional gravity simulation, achieving continuous and stable control of the microgravity environment. It also integrates continuous perfusion technology to dynamically renew culture medium, fundamentally solving the problem of metabolic waste accumulation in static culture and supporting the healthy growth and development of cells. The supporting microfluidic chip matrix uses diverse materials, which flexibly adapts to different scenarios like cell culture and drug screening, further expanding the system's application scope. In terms of functionality, it covers the entire process from basic mechanism exploration to preclinical testing, providing a complete solution for space life sciences, aerospace medicine, and regenerative medicine—essentially building a bridge between ground-based and space research.

产品优势：

1、聚焦空间医学专属需求，市面上的灌流培养系统（如赛多利斯、赛默飞产品）多以生物制药生产为核心方向，而本系统专为空间医学研发，可精准复现太空微重力环境；Tailored for space medicine needs: Most commercial perfusion systems (e.g., products from Sartorius, Thermo Fisher) focus on biopharmaceutical production, while this system is specifically developed for space medicine and can accurately reproduce the microgravity environment of space.

2 微重力控制更精准稳定，依托自主研发技术，突破了传统重力模拟的局限，稳定性远优于没有微重力控制功能的常规灌流系统；More precise and stable microgravity control: Built on independently developed technology, it breaks through the limitations of traditional gravity simulation, with stability far superior to conventional perfusion systems that lack microgravity control capabilities.

3、场景适配灵活性更高，多样化材质的微流控芯片矩阵，能适配空间医学领域的多维度实验需求，比同类仅支持单一场景的芯片设计更具优势；Higher flexibility in scenario adaptation: The microfluidic chip matrix with diverse materials can meet multi-dimensional experimental needs in space medicine, outperforming similar designs that only support single scenarios.

4、覆盖科研全流程支撑，从基础探索到临床前测试均能支持，而市面系统大多只侧重生产环节，难以提供科研全链条的支撑；Supports the entire scientific research process: It covers everything from basic exploration to preclinical testing, while most commercial systems only focus on production links and cannot provide support for the entire research chain.

5、定向赋能特色学科，针对性服务于航天医学与再生医学领域，市面上多数系统则以生物制药为核心应用场景（这一领域占比达 61.3%）；Targeted empowerment for specialized disciplines: It specifically serves the fields of aerospace medicine and regenerative medicine, while most commercial systems take biopharmaceuticals as their core application scenario (accounting for 61.3% of such systems).

6，降低资源依赖门槛，无需依赖航天任务就能开展太空相关研究，解决了传统空间实验面临的资源稀缺问题；Lowers resource dependence barriers: It enables space-related research without relying on aerospace missions, addressing the resource scarcity issue faced by traditional space experiments.

7，一体化技术集成方案，将微重力模拟与灌流技术深度融合，而市面系统往往需要额外配置专项模块（例如赛多利斯系统需单独集成 ATF 装置）；Integrated technology solution: It deeply integrates microgravity simulation and perfusion technology, while commercial systems often require additional configuration of special modules (e.g., Sartorius systems need separate integration of ATF devices).

应用场景

       赛吉生物 DARC-P2.0L 系统的应用场景，主要围绕空间医学及关联学科的科研需求展开。它既能支撑空间生物学领域的基础研究，比如探索微重力对细胞功能的影响；也能服务于航天医学的实际应用，像为航天员太空适应相关实验提供地面模拟条件。在再生医学方向，可辅助干细胞在微重力环境下的分化研究；药物研发领域，还能用于空间药效评估和代谢分析。另外，结合配套的微流控芯片，它还适用于多类型细胞共培养、疾病模型构建等场景，从基础机制探索到临床前测试的各个环节，都能提供符合空间医学特性的实验支持，帮科研人员解决传统设备难以复现太空环境的痛点。The application scenarios of Saige Bio's DARC-P2.0L system mainly center on the research needs of space medicine and related disciplines. It can not only support basic research in space biology, such as exploring the impact of microgravity on cell functions, but also serve practical applications in aerospace medicine—like providing ground simulation conditions for experiments related to astronauts' space adaptation. In the regenerative medicine field, it can assist in the research on stem cell differentiation under microgravity; in drug development, it can also be used for space drug efficacy evaluation and metabolism analysis. Additionally, combined with the supporting microfluidic chips, it is suitable for scenarios like multi-type cell co-culture and disease model construction. It provides space medicine-specific experimental support for all links from basic mechanism exploration to preclinical testing, helping researchers solve the pain point that traditional equipment cannot reproduce the space environment.

主要应用场景（但不限于）：

1、空间环境下三维类器官构建研究，Research on 3D organoid construction in simulated space environment.

2、微重力对细胞生物学效应的机制探索，Exploration of mechanisms underlying the biological effects of microgravity on cells.

3、航天医学中航天员生理适应预实验，Pre-experiments on astronauts' physiological adaptation in aerospace medicine.

4、再生医学领域干细胞微重力分化研究，Research on stem cell differentiation under microgravity in regenerative medicine.

5、空间药效评估中的药物代谢实验，Drug metabolism experiments in space drug efficacy evaluation.

6、微重力下细胞代谢废物影响的专项分析，Special analysis of the impact of cellular metabolic waste under microgravity.

7、航天相关疾病体外模型的构建与研究，Construction and research of in vitro models for space-related diseases.

8、新型空间医学检测技术的地面验证，Ground verification of new space medicine detection technologies.

9、微流控芯片适配的多细胞共培养实验，Multi-cell co-culture experiments adapted to microfluidic chips.

常见问答

关键字: 三维灌流培养,微重力模拟培养,3D灌流培养,连续灌流培养,微重力模拟灌流培养,航天医学研究